BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

The GREENFUND - we're buying the dip, big time, and here's why., page-26

  1. 4,340 Posts.
    lightbulb Created with Sketch. 2630
    Timetoletgo.Notalotofvalueindraggingthisout.Wehavemuchbetterunderstandingnow.Yes,therewasamajorstuffupandinternallytheywillbedealingwith.ExternallyItwillbeforgottenaboutasthismoveson-unlessdownrampersandotherswithquestionablemotiveschoosetorepeatthesamethingsoverandover.Canwemoveon?????
    Most of the posters who are not letting go are regulars and obviously not downrampers. All power to them because the reason for the aberrated US results given by management simply is not plausible. Management is saying there was a problem with production in the US of CBD but the distorted results are from those in the US who were not treated with CBD product. The quality of the CBD produced in the US is a red herring.

    I encourage genuine good faith contributors to keep asking the obvious question and demanding a fuller and more plausible explanation from management. The AGM is next Monday (?). The company should take the opportunity to come clean.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.0¢
Change
0.055(16.9%)
Mkt cap ! $687.8M
Open High Low Value Volume
33.0¢ 38.0¢ 33.0¢ $7.103M 19.63M

Buyers (Bids)

No. Vol. Price($)
5 134000 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 650314 19
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.